CMS has balked at covering vagus nerve stimulation for treatment-resistant depression. Positive results from an ...

A 10-month-old baby boy weighing only 5.5 kilos who suffers from epilepsy has undergone the implantation of a vagal-nerve stimulator (VNS) at the Galilee Medical Center in Nahariya. The vagus ...

The trial was investigating the use of vagus nerve stimulation (VNS) for inflammatory bowel disease (IBD), an autoimmune ...

Vagus nerve stimulation (VNS) is a neuromodulation therapy, which means it’s a treatment that changes the patterns of activity of your nerves. Vagus nerve stimulation can treat epilepsy ...

A group of University of Minnesota researchers is leading a global study to research the impacts of vagus nerve stimulation (VNS ... the left vagus nerve. While VNS is a Food and Drug Administration ...

Maintaining our emotional health can sometimes feel like an uphill battle. With the prevalence of mood disorders and the constant search for effective treatments, it’s no wonder that people are ...

VNS is an already-established treatment for conditions such as epilepsy, depression ... The vagus nerve stimulator segment is predicted to contribute $1bn to the market in 2033, as per GlobalData.

LivaNova will also present in-progress data from its contemporary real-world evidence study, "CORE-VNS: Comprehensive Outcomes Registry in Subjects With Epilepsy Treated With Vagus Nerve Stimulation ...

Market Opportunity Polaris Market Research estimates the global vagus nerve stimulation (VNS) market will grow ... for treatment-resistant epilepsy and depression, cluster and migraine headaches ...